We update you on efforts to identify treatments for the coronavirus, as well as policymakers’ discussions on when to reopen the economy, what that might look like, and where government funding should be directed. Continue Reading
In an updated post, Baker Institute health policy experts provide links to some of the sources that they found most helpful in understanding developments in the coronavirus outbreak and efforts to control it. Continue Reading
Nearly three years into his administration, President Trump has reestablished the President’s Council of Advisors on Science and Technology Policy (PCAST), which advises the White House on policy issues related to science, technology and innovation. However, the first round of appointments raises serious questions about the council. Continue Reading
Despite internal changes in how scientists are nominated for the Nobel Prize, there is still a substantial gender bias in prize recipients. Concrete policy changes are needed to ensure more diversity is reflected in the world’s most visible and prestigious scientific honor. Continue Reading
While the U.S. still maintains the overall lead in Nobel prizes (with the exception of literature), the rate at which American scientists have been awarded the prize has declined since the late 1970s. Continue Reading
Increasing vaccination rates throughout the state will help prevent future outbreaks of preventable diseases, which require millions of dollars for emergency response measures and compromise public and personal health. Reforming school-entry vaccination exemption policies will maximize public health benefits, cut health care costs and uphold personal liberties through increased informed consent. Continue Reading
We are building a strong evidence base that neglected tropical diseases (NTDs) are now widespread among the poorest people living in the United States. NTDs are unique poverty-related infections that cause long-term and debilitating effects. While they don’t command the… Continue Reading